CompletedPhase 4

Orphenadrine and Methocarbamol for LBP

United States240 participantsStarted 2016-03

Plain-language summary

Low back pain is a common cause of visit to emergency department. It is not clear if skeletal muscle relaxants are of benefit for patients with acute low back pain. This is a randomized study to determine if skeletal muscle relaxants, when combined with naproxen, improve outcomes more than naproxen alone

Who can participate

Age range18 Years – 69 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * LBP duration \<= 2 weeks * No trauma to low back within previous month * No radicular symptoms * No history of low back pain or history of only infrequent episodes Exclusion Criteria: * Medication allergies or contra-indications * Not available for follow-up * Chronic pain syndrome

What they're measuring

Functional Impairment as Measured on the Roland Morris Disability Questionnaire

Timeframe: 1 week

Trial details

NCT IDNCT02665286

SponsorMontefiore Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-04

Results submitted2018-04-30

View on ClinicalTrials.gov More Low Back Pain trials